Management of hepatocellular carcinoma: international guidelines

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma.

The aim of this review is to present the similarities and differences between the latest guidelines for noninvasive diagnosis of hepatocelullar carcinoma (HCC) of American Association for the Study of Liver Diseases (AASLD), European Association for the Study of the Liver (EASL), Asian Pacific Association for the Study of the Liver (APASL), and Japanese Society of Hepatology. All the four guide...

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer. This is the first European joint effort by the European Association for the Study of the Liver (EASL) and the European Organization for Research and Treatment of Cancer (EORTC) t...

Management of Hepatocellular Carcinoma

The rising incidence in the United States, as well as other parts of the world, is attributed largely to the increase in hepatitis C–related liver disease, a known risk factor for the disease.[2] In the United States alone, the seroprevalence of hepatitis C virus is estimated to be 3.9 million cases.[3] Other risk factors for HCC include hepatitis B viral infection, alcoholic cirrhosis, aflatox...

Hepatocellular Carcinoma in Sheep

Medical management of hepatocellular carcinoma.

The possibility of effective treatment of hepatocellular carcinoma (HCC), one of the most common cancers worldwide, largely depends on its detection at an early stage before symptoms develop. Screening patients with known cirrhosis, in whom the overall annual incidence of HCC development is of the order of 1-6% (1,2), has the potential to improve the detection rate of such asymptomatic tumors. ...